215 related articles for article (PubMed ID: 26754572)
21. In vivo and in vitro propagation of intraductal papillary mucinous neoplasms.
Kamiyama H; Kamiyama M; Hong SM; Karikari CA; Lin MT; Borges MW; Griffith M; Young A; Norris-Kirby A; Lubek C; Mizuma M; Feldmann G; Shi C; Liang H; Goggins MG; Maitra A; Hruban RH; Eshleman JR
Lab Invest; 2010 May; 90(5):665-73. PubMed ID: 20231822
[TBL] [Abstract][Full Text] [Related]
22. Intraductal papillary mucinous neoplasm: a clinicopathologic review.
Augustin T; Vandermeer TJ
Surg Clin North Am; 2010 Apr; 90(2):377-98. PubMed ID: 20362793
[TBL] [Abstract][Full Text] [Related]
23. Mixed ductal-endocrine carcinoma derived from intraductal papillary mucinous neoplasm (IPMN) of the pancreas identified by human telomerase reverse transcriptase (hTERT) expression.
Hashimoto Y; Murakami Y; Uemura K; Hayashidani Y; Sudo T; Ohge H; Sueda T; Shimamoto F; Hiyama E
J Surg Oncol; 2008 Apr; 97(5):469-75. PubMed ID: 18161862
[TBL] [Abstract][Full Text] [Related]
24. Telomere shortening and telomerase expression during multistage carcinogenesis of intraductal papillary mucinous neoplasms of the pancreas.
Hashimoto Y; Murakami Y; Uemura K; Hayashidani Y; Sudo T; Ohge H; Fukuda E; Shimamoto F; Sueda T; Hiyama E
J Gastrointest Surg; 2008 Jan; 12(1):17-28; discussion 28-9. PubMed ID: 17960465
[TBL] [Abstract][Full Text] [Related]
25. p16 and p53 gene alterations and accumulations in the malignant evolution of intraductal papillary-mucinous tumors of the pancreas.
Wada K
J Hepatobiliary Pancreat Surg; 2002; 9(1):76-85. PubMed ID: 12021900
[TBL] [Abstract][Full Text] [Related]
26. Loss of expression of the SWI/SNF chromatin remodeling subunit BRG1/SMARCA4 is frequently observed in intraductal papillary mucinous neoplasms of the pancreas.
Dal Molin M; Hong SM; Hebbar S; Sharma R; Scrimieri F; de Wilde RF; Mayo SC; Goggins M; Wolfgang CL; Schulick RD; Lin MT; Eshleman JR; Hruban RH; Maitra A; Matthaei H
Hum Pathol; 2012 Apr; 43(4):585-91. PubMed ID: 21940037
[TBL] [Abstract][Full Text] [Related]
27. Serum N-glycan profiles in patients with intraductal papillary mucinous neoplasms of the pancreas.
Akimoto Y; Nouso K; Kato H; Miyahara K; Dohi C; Morimoto Y; Kinugasa H; Tomoda T; Yamamoto N; Tsutsumi K; Kuwaki K; Onishi H; Ikeda F; Nakamura S; Shiraha H; Takaki A; Okada H; Amano M; Nishimura S; Yamamoto K
Pancreatology; 2015; 15(4):432-8. PubMed ID: 26052067
[TBL] [Abstract][Full Text] [Related]
28. Differential ezrin and phosphorylated ezrin expression profiles between pancreatic intraepithelial neoplasia, intraductal papillary mucinous neoplasm, and invasive ductal carcinoma of the pancreas.
Oda Y; Aishima S; Morimatsu K; Hayashi A; Shindo K; Fujino M; Mizuuchi Y; Hattori M; Tanaka M; Oda Y
Hum Pathol; 2013 Aug; 44(8):1487-98. PubMed ID: 23465281
[TBL] [Abstract][Full Text] [Related]
29. Intraductal papillary mucinous neoplasms of the pancreas (IPMNs): new insights on clinical outcomes and malignant progression.
Khouri J; Saif MW
JOP; 2014 Jul; 15(4):310-2. PubMed ID: 25076329
[TBL] [Abstract][Full Text] [Related]
30. Increased K-ras mutation and expression of S100A4 and MUC2 protein in the malignant intraductal papillary mucinous tumor of the pancreas.
Jang JY; Park YC; Song YS; Lee SE; Hwang DW; Lim CS; Lee HE; Kim WH; Kim SW
J Hepatobiliary Pancreat Surg; 2009; 16(5):668-74. PubMed ID: 19412570
[TBL] [Abstract][Full Text] [Related]
31. Cyst size indicates malignant transformation in branch duct intraductal papillary mucinous neoplasm of the pancreas without mural nodules.
Sadakari Y; Ienaga J; Kobayashi K; Miyasaka Y; Takahata S; Nakamura M; Mizumoto K; Tanaka M
Pancreas; 2010 Mar; 39(2):232-6. PubMed ID: 19752768
[TBL] [Abstract][Full Text] [Related]
32. Pancreatic mucinous noncystic (colloid) carcinomas and intraductal papillary mucinous carcinomas are usually microsatellite stable.
Lüttges J; Beyser K; Pust S; Paulus A; Rüschoff J; Klöppel G
Mod Pathol; 2003 Jun; 16(6):537-42. PubMed ID: 12808058
[TBL] [Abstract][Full Text] [Related]
33. MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas.
Masuda A; Arisaka Y; Hara S; Matsumoto I; Takenaka M; Sakai A; Shiomi H; Matsuki N; Sugimoto M; Fujita T; Hayakumo T; Ku Y; Ogino S; Azuma T; Kutsumi H
Pancreatology; 2013; 13(6):583-8. PubMed ID: 24280573
[TBL] [Abstract][Full Text] [Related]
34. Differential roles of alterations of p53, p16, and SMAD4 expression in the progression of intraductal papillary-mucinous tumors of the pancreas.
Sasaki S; Yamamoto H; Kaneto H; Ozeki I; Adachi Y; Takagi H; Matsumoto T; Itoh H; Nagakawa T; Miyakawa H; Muraoka S; Fujinaga A; Suga T; Satoh M; Itoh F; Endo T; Imai K
Oncol Rep; 2003; 10(1):21-5. PubMed ID: 12469138
[TBL] [Abstract][Full Text] [Related]
35. S100P is a novel marker to identify intraductal papillary mucinous neoplasms.
Nakata K; Nagai E; Ohuchida K; Hayashi A; Miyasaka Y; Aishima S; Oda Y; Mizumoto K; Tanaka M; Tsuneyoshi M
Hum Pathol; 2010 Jun; 41(6):824-31. PubMed ID: 20153506
[TBL] [Abstract][Full Text] [Related]
36. [Pancreatic tumor: progress in diagnosis and treatment. Topics: II. Intraductal papillary mucinous neoplasm of the pancreas (IPMN)/mucinous cystic neoplasm (MCN); 2. Pathology and pathobiology].
Furukawa T; Kuboki Y; Hatori T; Yamamoto M; Shibata N; Shiratori K
Nihon Naika Gakkai Zasshi; 2012 Jan; 101(1):57-63. PubMed ID: 22413462
[No Abstract] [Full Text] [Related]
37. Expression of SOX9 in intraductal papillary mucinous neoplasms of the pancreas.
Meng F; Takaori K; Ito T; Masui T; Kawaguchi M; Kawaguchi Y; Uemoto S
Pancreas; 2014 Jan; 43(1):7-14. PubMed ID: 24212241
[TBL] [Abstract][Full Text] [Related]
38. Increased SOX9 Expression in Premalignant and Malignant Pancreatic Neoplasms.
Gnerlich JL; Ding X; Joyce C; Turner K; Johnson CD; Chen H; Abood GJ; Pappas SG; Aranha GV
Ann Surg Oncol; 2019 Feb; 26(2):628-634. PubMed ID: 30357576
[TBL] [Abstract][Full Text] [Related]
39. Characteristic clinicopathological features of the types of intraductal papillary-mucinous neoplasms of the pancreas.
Ishida M; Egawa S; Aoki T; Sakata N; Mikami Y; Motoi F; Abe T; Fukuyama S; Sunamura M; Unno M; Moriya T; Horii A; Furukawa T
Pancreas; 2007 Nov; 35(4):348-52. PubMed ID: 18090241
[TBL] [Abstract][Full Text] [Related]
40. Histopathological study of intraductal papillary mucinous tumor of the pancreas: special reference to the roles of Survivin and p53 in tumorigenesis of IPMT.
Jinfeng M; Kimura W; Sakurai F; Moriya T; Takeshita A; Hirai I
Int J Gastrointest Cancer; 2002; 32(2-3):73-81. PubMed ID: 12794243
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
